Corcept Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Corcept Therapeutics Stock Forecast and Price Target
If Corcept Therapeutics's stock price reached the average yearlong target of $38.00 given by four well-known analysts in recent months, there would be a potential upside of approximately 69.04% from its last closing price in April, 2024. This potential increase is based on a high estimate of $61.00 and a low estimate of $35.00. If you are interested in CORT stock, it is important to also consider its competitors.
69.04% Upside
Corcept Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Corcept Therapeutics's Price has decreased by 100.00%, going from $23.45 to $0.00. For next year, analysts predict Fair Value of $18.64, which would mean an increase of 100.00%. Over the next seven years, experts predict that Corcept Therapeutics's Fair Value will grow at a rate of 100.00%.
Corcept Therapeutics Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Corcept Therapeutics's Revenue has grown by 36.32%, rising from $353.87M to $482.38M. For next year, analysts predict Revenue of $535.35M, which would mean an increase of 10.98%. Over the next seven years, experts predict that Corcept Therapeutics's Revenue will grow at a rate of 186.90%.
.jpg)
Corcept Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Corcept Therapeutics's EBITDA has decreased from $128.73M to $108.32M – a 15.85% drop! In the next year, analysts believe that EBITDA will reach $136.80M – an increase of 26.29%. For the next seven years, the forecast is for EBITDA to grow by 147.23%.
Corcept Therapeutics EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Corcept Therapeutics has seen a decline in its EBIT, from $128.20M to $107.28M – a 16.32% decrease. For the next year, analysts predict that EBIT will reach $127.38M – an increase of 18.74%. Over the next seven years, experts believe that Corcept Therapeutics's EBIT will grow at a rate of 706.57%.
Corcept Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Corcept Therapeutics's EPS has decreased by 100.00%, going from $1.17 to $0.00. For next year, analysts predict EPS of $0.93, which would mean an increase of 100.00%. Over the next seven years, experts predict that Corcept Therapeutics's EPS will grow at a rate of 100.00%.
.jpg)